Treatment with Uptravi (selexipag) was shown to be safe and reduced the risk of pulmonary arterial hypertension (PAH)…
Articles by Alice Melão, MSc
Prucalopride, marketed under the name Resolor in Europe and Resotran in Canada, can safely manage mild to severe gastrointestinal (GI)…
Researchers found that scleroderma renal crisis (SRC), a severe complication of systemic sclerosis (SSc), is associated with high mortality in Thai…
Systemic sclerosis patients with interstitial lung disease (SSc-ILD) have a great deal of symptoms and comorbidities (other diseases), with a…
Inventiva’s lead therapy candidate IVA337 for the treatment of systemic sclerosis (SSc) was shown to prevent…
Scleroderma patients without pulmonary arterial hypertension (PAH) were found to develop a mild but significant decline in the ability to exercise…
The American Medical Association is adding descriptions of Cytori Therapeutics’ cell-based therapy for scleroderma of the hands to its authoritative database of…
The U.S. Patent and Trademark Office has granted Galectin Therapeutics a new patent…
An imaging technique called nailfold videocapillaroscopy and a blood-based detection of systemic sclerosis (SSc)…
Scientific advances have allowed researchers to develop therapies for pulmonary arterial hypertension (PAH) that have been shown to benefit…